Sp316

CONTEXT IS KEY: WHEN TO CONSIDER PROBIOTICS OR MICROBIOME TESTING FOR NEONATES, INFANTS, AND CHILDREN

Date
May 18, 2024

Presenter

Speaker Image for Geoffrey Preidis
Baylor College of Medicine & Texas Children's Hospital

Tracks

Related Products

Thumbnail for BILE SALT HYDROLASE ACTIVITY AND GUT MICROBIOME MATURATION ARE IMPAIRED IN PRETERM CHOLESTATIC INFANTS
BILE SALT HYDROLASE ACTIVITY AND GUT MICROBIOME MATURATION ARE IMPAIRED IN PRETERM CHOLESTATIC INFANTS
BACKGROUND: Physiologic cholestasis is prevalent in preterm infants, occurring in ~15% of preterm births. Cholestasis causes poor neonatal growth and may progress to liver failure and death. Underlying causes of most cases are unknown…
Thumbnail for Myths, Facts and Mysteries Surrounding the Microbiome
Myths, Facts and Mysteries Surrounding the Microbiome
SOCIETY: AGA This session will focus on the current debates about utility of small intestinal microbiome, probiotics and microbiome testing. The first debate will focus on "The Microbiome Conundrum: Unraveling the Influence of Small Intestinal Microbes on GI Symptoms - Debating Our Path Ahead"…
Thumbnail for Tiny Ecosystems, Big Impact: Unlocking the Secrets of the Early Life Microbiome
Tiny Ecosystems, Big Impact: Unlocking the Secrets of the Early Life Microbiome
SOCIETY: AGA This session is focused on the early life microbiome and its importance for immune maturation that affects both childhood diseases as well as future development of allergic and autoimmune diseases…
Thumbnail for Microbiome Modulation Across the Lifespan to Treat Chronic Diseases
Microbiome Modulation Across the Lifespan to Treat Chronic Diseases
SOCIETY: AGA In this session, presenters will provide insights into pioneering nutrition interventions and microbiome modulation strategies from studies that span both pediatric and adult patients…